Document is current
Any future updates will be listed below
-
Authors
Dautricourt, Sophie
Gonneaud, Julie
Landeau, Brigitte
Calhoun, Vince D.
de Flores, Robin
Poisnel, Géraldine
Bougacha, Salma
Ourry, Valentin
Touron, Edelweiss
Kuhn, Elizabeth
Demintz-King, Harriet
Marchant, Natalie L.
Vivien, Denis
de la Sayette, Vincent
Lutz, Antoine
Chételat, Gaël
,
Arenaza-Urquijo, Eider M.
Allais, Florence
André, Claire
Asselineau, Julien
Bejanin, Alexandre
Champetier, Pierre
Chételat, Gaël
Chocat, Anne
Dautricourt, Sophie
de Flores, Robin
Delarue, Marion
Egret, Stéphanie
Felisatti, Francesca
Devouge, Eglantine Ferrand
Frison, Eric
Gonneaud, Julie
Heidmann, Marc
Tran, Thien Huong
Kuhn, Elizabeth
le Du, Gwendoline
Landeau, Brigitte
Lefranc, Valérie
Lutz, Antoine
Mezenge, Florence
Moulinet, Inès
Ourry, Valentin
Palix, Cassandre
Paly, Léo
Poisnel, Géraldine
Quillard, Anne
Rauchs, Géraldine
Rehel, Stéphane
Requier, Florence
Touron, Edelweiss
Vivien, Denis
Ware, Caitlin
Lugo, Sebastian Baez
Klimecki, Olga
Vuilleumier, Patrik
Barnhofer, Thorsten
Collette, Fabienne
Salmon, Eric
de la Sayette, Vincent
Delamillieure, Pascal
Batchelor, Martine
Beaugonin, Axel
Gheysen, Francis
Demnitz-King, Harriet
Marchant, Natalie
Whitfield, Tim
Schimmer, Corinne
Wirth, Miranka
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 6 April 2022
First Online: 23 May 2022
Declarations
:
: All participants gave their written informed consent prior to the examinations, and the Age-Well RCT was approved by the local ethics committee (CPP Nord-Ouest III, Caen; trial registration number: EudraCT: 2016-002441-36; IDRCB: 2016-A01767-44; Identifier: NCT02977819).
: Not applicable.
: GC has received research support from the EU’s Horizon 2020 research and innovation programme (grant agreement number 667696), Inserm, Fondation d’entreprise MMA des Entrepreneurs du Futur, Fondation Alzheimer, Programme Hospitalier de Recherche Clinique, Région Normandie, Association France Alzheimer et maladies apparentées and Fondation Vaincre Alzheimer (all to Inserm), and personal fees from Fondation d’entreprise MMA des Entrepreneurs du Futur. All other authors have no relevant financial or non-financial interests to disclose.
